Press Releases

Date Headline
1/7/2021
Zymeworks to Present at J.P. Morgan Healthcare Conference and Host Two Webcasts in January to Provide Updates on its Lead Clinical Programs Zanidatamab and ZW49
 Summary
VANCOUVER, British Columbia--(BUSINESS WIRE)-- Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present at the upcoming 39 th  Annual J.P. Morgan Healthcare Conference.  Continue Reading
Displaying 21 - 21 of 21
Copyright 2021 , Zymeworks Inc.